MX2017004516A - Métodos y sistemas para distinguir el síndrome del intestino irritable de la enfermedad inflamatoria intestinal y la enfermedad celíaca. - Google Patents
Métodos y sistemas para distinguir el síndrome del intestino irritable de la enfermedad inflamatoria intestinal y la enfermedad celíaca.Info
- Publication number
- MX2017004516A MX2017004516A MX2017004516A MX2017004516A MX2017004516A MX 2017004516 A MX2017004516 A MX 2017004516A MX 2017004516 A MX2017004516 A MX 2017004516A MX 2017004516 A MX2017004516 A MX 2017004516A MX 2017004516 A MX2017004516 A MX 2017004516A
- Authority
- MX
- Mexico
- Prior art keywords
- disease
- methods
- systems
- celiac disease
- inflammatory bowel
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
- G01N2333/205—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Campylobacter (G)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/06—Gastro-intestinal diseases
- G01N2800/065—Bowel diseases, e.g. Crohn, ulcerative colitis, IBS
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Rheumatology (AREA)
- Rehabilitation Therapy (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
En la presente se describen métodos y sistemas para distinguir el síndrome de intestino irritable (IBS) de la enfermedad inflamatoria intestinal (IBD) y la enfermedad celíaca. Los métodos y sistemas pueden utilizar la detección de anticuerpos anti-vinculina y anticuerpos anti-CdtB para distinguir el IBS de la IBD y la enfermedad celíaca. Además se describen métodos para seleccionar una terapia para tratar el IBS, la IBD o la enfermedad celíaca.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201462061877P | 2014-10-09 | 2014-10-09 | |
US201462085825P | 2014-12-01 | 2014-12-01 | |
PCT/US2015/054655 WO2016057772A1 (en) | 2014-10-09 | 2015-10-08 | Methods and systems for distinguishing irritable bowel syndrome from inflammatory bowel disease and celiac disease |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2017004516A true MX2017004516A (es) | 2017-10-12 |
Family
ID=55653760
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2017004516A MX2017004516A (es) | 2014-10-09 | 2015-10-08 | Métodos y sistemas para distinguir el síndrome del intestino irritable de la enfermedad inflamatoria intestinal y la enfermedad celíaca. |
Country Status (13)
Country | Link |
---|---|
US (2) | US10132814B2 (es) |
EP (1) | EP3204771A4 (es) |
JP (1) | JP6784669B2 (es) |
KR (1) | KR102426541B1 (es) |
CN (1) | CN107003308B (es) |
AU (1) | AU2015330872B2 (es) |
CA (1) | CA2962493C (es) |
IL (1) | IL251606B (es) |
MX (1) | MX2017004516A (es) |
NZ (1) | NZ730490A (es) |
RU (1) | RU2706361C2 (es) |
SG (1) | SG11201702395WA (es) |
WO (1) | WO2016057772A1 (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11693009B2 (en) | 2009-02-11 | 2023-07-04 | Cedars-Sinai Medical Center | Methods for detecting post-infectious irritable bowel syndrome |
DK2396652T3 (da) | 2009-02-11 | 2018-01-29 | Cedars Sinai Medical Center | Diagnose af inflammatorisk tarmsyndrom baseret på cytoletalt udspilende toksin |
AU2013315981B2 (en) | 2012-09-17 | 2019-04-18 | Cedars-Sinai Medical Center | Diagnosis and treatment of motility disorders of the gut and bladder, and of fibromyalgia |
JP6567509B2 (ja) | 2013-10-09 | 2019-08-28 | シーダーズ−サイナイ メディカル センター | 過敏性腸症候および炎症性腸疾患の診断および治療 |
NZ730490A (en) | 2014-10-09 | 2021-07-30 | Cedars Sinai Medical Center | Methods and systems for distinguishing irritable bowel syndrome from inflammatory bowel disease and celiac disease |
EP3913371A1 (en) | 2020-05-18 | 2021-11-24 | Neuroimmun GmbH | Method and kit for diagnosting irritable bowel syndrome and for its relief through dietary interventions |
CN114895025A (zh) * | 2021-07-01 | 2022-08-12 | 浙江大学 | 一种检测抗粘着斑蛋白-IgG抗体的试剂盒 |
Family Cites Families (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
US5691151A (en) | 1994-10-07 | 1997-11-25 | Regents Of University Of California | Methods of screening for ulcerative colitis and crohn's disease by detecting VH3-15 autoantibody and panca |
US6562629B1 (en) | 1999-08-11 | 2003-05-13 | Cedars-Sinai Medical Center | Method of diagnosing irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth by detecting the presence of anti-saccharomyces cerivisiae antibodies (asca) in human serum |
US6861053B1 (en) | 1999-08-11 | 2005-03-01 | Cedars-Sinai Medical Center | Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth |
US7048906B2 (en) | 1995-05-17 | 2006-05-23 | Cedars-Sinai Medical Center | Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions |
FR2806805A1 (fr) | 2000-03-22 | 2001-09-28 | Centre Nat Rech Scient | SEQUENCE PEPTIDIQUES COMPRENANT UN OU PLUSIEURS MOTIFS DE LIAISON AUX PROTEINES DE LA FAMILLE Ena/VASP, ET LEURS UTILISATIONS |
AU2007201246B2 (en) | 2001-04-17 | 2008-12-04 | Cedars-Sinai Medical Center | Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions |
AU2003233576A1 (en) | 2002-05-17 | 2003-12-02 | Sugen, Inc. | Novel biomarkers of tyrosine kinase inhibitor exposure and activity in mammals |
AU2003291625B2 (en) | 2002-09-16 | 2009-10-08 | Genentech, Inc. | Compositions and methods for the treatment of immune related diseases |
US7595386B2 (en) | 2003-01-24 | 2009-09-29 | William Beaumont Hospital | Methods and compositions for heat activated gene therapy using cytolethal distending toxin |
CA2537818A1 (en) | 2003-09-15 | 2005-03-31 | Oklahoma Medical Research Foundation | Method of using cytokine assays to diagnose, treat, and evaluate inflammatory and autoimmune diseases |
DK1698698T3 (da) | 2003-12-05 | 2014-05-12 | Fuso Pharmaceutical Ind | Cytolethaldistenderende toksingener som mål for detektering af campylobacterbakterier |
US20080085524A1 (en) * | 2006-08-15 | 2008-04-10 | Prometheus Laboratories Inc. | Methods for diagnosing irritable bowel syndrome |
EP2102367A2 (en) | 2006-11-09 | 2009-09-23 | XDX, Inc. | Methods for diagnosing and monitoring the status of systemic lupus erythematosus |
CA2747253A1 (en) * | 2007-12-20 | 2009-07-02 | Index Diagnostics Ab | Method and kit for use in the differentiation of ibd and ibs and further distinction between disease types of ibd |
WO2010045180A1 (en) * | 2008-10-13 | 2010-04-22 | Metabolon, Inc. | Biomarkers for inflammatory bowel disease and methods using the same |
KR101493125B1 (ko) | 2008-11-24 | 2015-02-12 | 세다르스-신나이 메디칼 센터 | 항산화성 캠토테신 유도체 및 이들의 항산화성 항종양성 나노구체 |
DK2396652T3 (da) | 2009-02-11 | 2018-01-29 | Cedars Sinai Medical Center | Diagnose af inflammatorisk tarmsyndrom baseret på cytoletalt udspilende toksin |
BRPI1008058A8 (pt) | 2009-02-11 | 2018-03-27 | Cedars Sinai Medical Center | uso de antibióticos para reduzir a probabilidade de desenvolver síndrome do intestino irritável pós-infecciosa |
FR2942541A1 (fr) | 2009-02-25 | 2010-08-27 | Assist Publ Hopitaux De Paris | Procede de diagnostic d'une vascularite |
RU2397178C1 (ru) * | 2009-02-27 | 2010-08-20 | Федеральное государственное учреждение науки "Центральный научно-исследовательский институт эпидемиологии" Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека | Диагностическая тест-система в формате иммуночипа и способ серологической дифференциальной диагностики сифилиса |
IT1400989B1 (it) | 2010-07-13 | 2013-07-05 | Segix Italia S R L Ora Istituto Biochimico Naz Savio S R L | Forme di somministrazione orale a rilascio controllato di rifampicina per il trattamento di infezioni batteriche dell' apparato intestinale. |
GB201017520D0 (en) | 2010-10-15 | 2010-12-01 | Sense Proteomic Ltd | Biomarkers |
JP5477671B2 (ja) | 2012-02-28 | 2014-04-23 | 三菱マテリアル株式会社 | サーミスタ用金属窒化物材料及びその製造方法並びにフィルム型サーミスタセンサ |
AU2013315981B2 (en) | 2012-09-17 | 2019-04-18 | Cedars-Sinai Medical Center | Diagnosis and treatment of motility disorders of the gut and bladder, and of fibromyalgia |
JP6567509B2 (ja) | 2013-10-09 | 2019-08-28 | シーダーズ−サイナイ メディカル センター | 過敏性腸症候および炎症性腸疾患の診断および治療 |
NZ730490A (en) | 2014-10-09 | 2021-07-30 | Cedars Sinai Medical Center | Methods and systems for distinguishing irritable bowel syndrome from inflammatory bowel disease and celiac disease |
JP2020507755A (ja) | 2017-01-30 | 2020-03-12 | シーダーズ−サイナイ メディカル センター | 強皮症の診断法 |
-
2015
- 2015-10-08 NZ NZ730490A patent/NZ730490A/en unknown
- 2015-10-08 KR KR1020177011301A patent/KR102426541B1/ko active IP Right Grant
- 2015-10-08 SG SG11201702395WA patent/SG11201702395WA/en unknown
- 2015-10-08 WO PCT/US2015/054655 patent/WO2016057772A1/en active Application Filing
- 2015-10-08 EP EP15849701.6A patent/EP3204771A4/en active Pending
- 2015-10-08 US US14/878,416 patent/US10132814B2/en active Active
- 2015-10-08 JP JP2017518834A patent/JP6784669B2/ja active Active
- 2015-10-08 RU RU2017115663A patent/RU2706361C2/ru active IP Right Revival
- 2015-10-08 MX MX2017004516A patent/MX2017004516A/es unknown
- 2015-10-08 AU AU2015330872A patent/AU2015330872B2/en active Active
- 2015-10-08 CN CN201580067387.5A patent/CN107003308B/zh active Active
- 2015-10-08 CA CA2962493A patent/CA2962493C/en active Active
-
2017
- 2017-04-05 IL IL251606A patent/IL251606B/en active IP Right Grant
-
2018
- 2018-10-05 US US16/152,806 patent/US10690679B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
EP3204771A4 (en) | 2018-03-14 |
KR20170067795A (ko) | 2017-06-16 |
IL251606B (en) | 2020-08-31 |
RU2017115663A3 (es) | 2019-05-16 |
US20190187153A1 (en) | 2019-06-20 |
US10690679B2 (en) | 2020-06-23 |
IL251606A0 (en) | 2017-06-29 |
RU2017115663A (ru) | 2018-11-13 |
RU2706361C2 (ru) | 2019-11-18 |
EP3204771A1 (en) | 2017-08-16 |
NZ730490A (en) | 2021-07-30 |
CN107003308A (zh) | 2017-08-01 |
AU2015330872A1 (en) | 2017-04-13 |
CA2962493C (en) | 2023-01-10 |
SG11201702395WA (en) | 2017-04-27 |
JP2017531801A (ja) | 2017-10-26 |
JP6784669B2 (ja) | 2020-11-11 |
AU2015330872B2 (en) | 2021-04-22 |
CN107003308B (zh) | 2020-02-11 |
CA2962493A1 (en) | 2016-04-14 |
WO2016057772A1 (en) | 2016-04-14 |
KR102426541B1 (ko) | 2022-07-29 |
US20160103136A1 (en) | 2016-04-14 |
US10132814B2 (en) | 2018-11-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2017004516A (es) | Métodos y sistemas para distinguir el síndrome del intestino irritable de la enfermedad inflamatoria intestinal y la enfermedad celíaca. | |
PH12020550781A1 (en) | Anti-jagged1 antibodies and methods of use | |
PH12017500861A1 (en) | Anti-interleukin-33 antibodies and uses thereof | |
MY194686A (en) | Detection of chromosome interactions | |
PH12017500877A1 (en) | ANTI-CD79b ANTIBODIES AND METHODS OF USE | |
MX2017016647A (es) | Anticuerpos y fragmentos anti-vista. | |
PH12016501894A1 (en) | Anti-ox40 antibodies and methods of use | |
MY193661A (en) | Anti-tim3 antibodies and methods of use | |
EP3156498A4 (en) | Breast cancer detection kit or device, and method for detecting breast cancer | |
NZ761537A (en) | Anti-human ox40l antibodies, uses & methods | |
MX2017001981A (es) | Inhibidores de diana de rapamicina en celulas de mamifero de complejo 1 (mtorc1). | |
MX2017000840A (es) | Metodo para predecir el resultado de un tratamiento con aflibercept de un paciente que se sospecha que padece un cancer. | |
MX2017005888A (es) | Dispositivos, sistemas y metodos para la deteccion de analitos. | |
MX2023006415A (es) | Anticuerpos, usos y metodos. | |
MA40636A (fr) | Procédés pour détecter le cancer de la prostate | |
MX2016016233A (es) | Anticuerpos anti-lgr5 y sus usos. | |
EP3177298A4 (en) | Methods for treating inflammatory bowel disease using prostate specific membrane antigen (psma) inhibitors | |
TR201909125T4 (tr) | Yüzey temi̇zlemek i̇çi̇n bi̇r aparat | |
EP3107079A4 (en) | Detector, detection method, detection system, program | |
EA201691203A1 (ru) | Твёрдые формы тенофовира | |
MY192194A (en) | Method and kit for simultaneous and rapid detection of prawn viruses | |
IL248458A0 (en) | Cry1ca-specific monoclonal antibodies and related detection methods | |
GB201817889D0 (en) | Microorganism detection methods | |
MX2016009918A (es) | Diagnostico molecular de microplasmas. | |
NZ765619A (en) | Genes and gene signatures for diagnosis and treatment of melanoma |